Healthcare company-building profile
UCSF Rosenman Institute
UCSF Health / University of California, San Francisco (QB3)
Source-based profile
Program at a Glance
- Program type
- Accelerator
- Program category
- Health system accelerator
- Organization
- UCSF Health / University of California, San Francisco (QB3)
- Organization type
- Hospital or health system
- Location
- San Francisco, California
- Company stage served
- Early stage
- Cohort or participation model
- Not publicly documented
- Investment or funding offered
- Not publicly documented
- Published investment terms
- Not publicly documented
- Equity or fee model
- Not publicly documented
- Clinical or hospital connection
- Yes
- Application status
- Active
Public description
About the program
The UCSF Rosenman Institute supports healthtech entrepreneurs, including UCSF clinicians, in moving medical device and digital health concepts toward commercialization. Its Rosenman Innovators program selects early-stage companies each year and connects them to a curated network of clinicians, industry experts, corporate partners and investors, while the Rosenman Fellowship supports academic innovators in identifying and validating unmet clinical needs. The institute also runs UCSF Rosenman ADAPT, which pairs startups with large healthcare companies for scaling partnerships, and Rosenman RISE, a mentorship and networking track for underrepresented entrepreneurs. In 2022 the institute partnered with the UCSF Division of Cardiology to fast-track cardiovascular health technology through a dedicated fellowship program.
What the program publicly emphasizes
Focus areas and features
- Category: Health system accelerator
Publicly documented people and network
Program leadership and alumni
- Notable alumni named in public materials
- Named Rosenman Innovator companies include Fibralign, Perceptive Navigation (Dr. Ted Abraham), BRIUS (Dr. Mehdi Peikar) and Moving Analytics; BRIUS credits program introductions with producing a COO hire, a board director and a consultant; Moving Analytics credits Rosenman investor exposure with two investors joining its funding round; partnership with UCSF Division of Cardiology launched in 2022-2023 to accelerate cardiovascular technology
Sources
External source links open in a new tab.